|
|
| Poster sessions |
| Alopecia Areata |
| |
P7.71
Observations on the external application of microelements
in alopecia areata treatment
W. Garncarz. Wroclaw, Poland. |
P7.72
The progressive alopecia areata disease state and therapeutic
response towards a contact sensitizer are reflected in
peripheral blood mononuclear cells
K. J. McElwee, P. Freyschmidt-Paul, M. Zöller, M. Vitacolonna
and R. Hoffmann. Marburg and Heidelberg, Germany. |
P7.73
Apoptosis resistance in peripheral blood lymphocytes
of alopecia areata patients
K. J. McElwee, P. Freyschmidt-Paul, M. Zöller and R.
Hoffmann. Marburg, Freiburg and Heidelberg, Germany. |
P7.74
Alopecia areata: do these subjects have common personality
traits?
R. d’Ovidio, J. Claudatus and T. Di Prima. Catania,
Italy. |
P7.75
Clinical significance of the HLA-DR11 positive subset
in patients with alopecia areata
C. Marques Da Costa, J.J. Stene, E. Dupont, M. Vandercruys,
M. Hidajat and M. Andrien. Bruxelles, Belgium. |
P7.76
Alopecia areata : topical treatment with anthralin (cignolin)
G. Staib and K. Scharfetter-Kochanek. Ulm, Germany. |
P7.77
Children with alopecia areata – analysis of the Cleveland
Clinic Foundation experience
W. F. Bergfeld, N. C. Dombrowski, B. K. Remzi and J.
M. Leonhardt. Cleveland, USA. |
P7.78
Alopecia areata in eyebrows treated with superficial
cryotherapy: case reports
Soo Young Jeon, Bong Kyun Ahn, Sanghoon Lee and Won-Soo
Lee. Wonju, Korea. |
P7.79
Correlation between disease duration and the effect of
methylprednisolone pulse therapy for alopecia areata
J. K. Park, M. Im, M. S. Park, Y. J. Seo and J. H.
Lee. Teajon, Korea. |
P7.80
The optimal dose of topical diphenylcylopropenone sensitization
for the treatment of alopecia areata: preliminary study
M. Im, Y. Joon Seo, J. H. Lee and J. K. Park. Teajon,
Korea. |
P7.81
Adult onset alopecia areata is a complex polygenic trait
in the C3H/HEJ mouse
J. P. Sundberg, K. Silva, R. Li, G.A. Cox and L. E.
King. Bar Harbor and Nashville, USA. |
P7.82
Phylogenetic tissue arrays for comparison of alopecia
areata between species
J. P. Sundberg, J. Miller, K. McElwee, T. Olivry, R.
D., T. L. Gross, S. Whitehead, D. Whiting, M. Hogan
and L. E. King. Bar Harbor, Marburg, Raleigh, Texas,
West Sacramento, Nashville, Dallas and San Diego, Germany
and USA. |
P7.83
A TH1 - associated anti-hair follicle IgG1 antibody response
predominates in human alopecia areata
M. L. O’Shea, L. Mooney, J.-C. Bystryn and D. J. Tobin.
Bradford and New York, UK and USA. |
P7.84
Alopecia areata of children in Korea (1991-2003)
J. Y. Ahn, J. E. Kim and B. I. Ro. Seoul, Korea. |
P7.85
Clinical evaluation of linear polarized infrared irradiation
using super lizertm for chronic stable alopecia areata
patients
U. Rie, M. Mio and O. Hedeoki. Tokyo, Japan. |
P7.86
CD4+ killer T cells are involved in the alopecia areata
A. Mukuno, H. Tsuboi, T. Fujimura, Y. Hamada and K.
Katsuoka. Sagamihara and Yokohama, Japan. |
P7.87
A controlled study of liquid nitrogen efficacy in treatment
of alopecia areata involving less than 25% of the scalp
B. Matard, C. Jouanique, S. Abdennader, V. Saada, F.
Nico, P. Assouly and P. Reygagne. Paris, France. |
P7.88
Successful treatment of alopecia areata with imiquimod
5% cream
S. Hezel, T. Schmook, I. Nindl, N. Mandt, J. Röwert,
W. Sterry and E. Stockfleth. Berlin, Germany. |
P7.150
The efficacy low dose cyclosporine a in patients with
alopecia areata
A. Tarajkowska–Olejnik, M. S³owiñska and L. Rudnicka.
Warsaw, Poland. |
| |
| Hair Disorders -
Clinical Aspects |
| |
P8.89
The Köbner phenomenon in trichology
R. d’Ovidio, J. Claudatus and T. Di Prima. Catania,
Italy. |
P8.90
A case of keratosis pilaris decalvans and acne keloidalis
nuchae
A. H. Chong, Victoria, Australia. |
P8.91
New hypothesis about common baldness
A. J. Soler. Alicante, Spain. |
P8.92
Scarring alopecia – manifestation of different skin diseases
L. Oremoviæ, I. Sjerobabski Masnec and L. Lugoviæ.
Zagreb, Croatia. |
P8.93
A case of central trichoptilosis with nail dystrophy
Y. H. Nam, M. Im, Y. J. Seo, J. H. Lee and J. K. Park.
Teajon, Korea. |
P8.94
Red meat consumption in the UK has declined over the
past 15 years with significant health consequences for
the UK adult population potentially leading to more women
and men developing chronic telogen effluvium
N. Frigé and D. H. Rushton. Portsmouth, UK. |
P8.95
Diffuse non-scarring alopecia- a study of 3,500 cases
S. Murugusundram, S. Shivakumar and P. Yesudian. Chennai,
India. |
P8.96
Trichotillomania – an important cause of diffuse alopecia
S. Murugusundram, S. Shivakumar and P. Yesudian. Chennai,
India. |
P8.97
The question of whether low serum ferritin is associated
with hair loss in women. With a related discussion as
to whether other nutritional factors have any influence
on hair shedding as evaluated in a survey of 2,147 women
R. Lurie. Petah Tiqva,Tel Aviv and Kupat-Holim Clalit,
Israel. |
P8.98
Nevoid basal cell carcinoma syndrome with multiple hair
shaft defects
R. Lurie, D. M. Michael and E. Hodak. Petah Tivka,
Israel. |
P8.99
An unusual case of perifolliculitis abscedens et suffodiens
M. Ramos, R. Ferrusco and M. Rodriguez. Zapopan, Mexico. |
P8.100
Generalized hypotrichosis with features of loose anagen
hair syndrome- report of a family with autosomal dominant
inheritance
S.-J. Lin, S.-H. Jee and H.-C. Chiu. Taipei, Taiwan. |
P8.101
Alopecia areata associated with pityriasis lichenoides
et varioliformis acuta and nevus flammeus
W. Chen, C.-C. Yang, S.-C. Chao and J. Y.-Y. Lee. Kaohsiung
and Tainan, Taiwan. |
P8.102
Patients with large prostate size show higher prevalence
of androgenetic alopecia
C.-C. Yang, T.-S. Tzai, M.-C. Wu and W. Chen. Tainan
and Kaohsiung, Taiwan. |
P8.103
A clinical study of androgenetic alopecia (2002-2003)
J. E. Kim, J. Y. Ahn and B. I. Ro. Seoul, Korea. |
P8.104
Primary cicatricial alopecias background
R. M. Ngwanya. Cape Town, South Africa. |
P8.105
Autosomal dominant familial loose anagen hair syndrome
associated with absence of vellus hair and generalized
hypotrichosis - study of a family with 25 patients
S.-J. Lin, S.-H. Jee and H.-C. Chiu. Taipei, Taiwan. |
P8.106
Postmenopausal frontal fibrosing alopecia
L. Török, Á. Kirscher and Sz. Németh. Kecskemét, Hungary. |
P8.107
Netherton´s disease in two siblings- a five-year follow
up
N. Mandt, J. Vieten, K. Zappel, S. Blind and U. Blume-Peytavi.
Berlin,
Germany. |
P8.108
Two cases of tufted folliculitis
N. O. Koch. Jalisco, Mexico. |
P8.109
Mechanisms of endogenous skin aging
E. Makrantonaki, S. Fimmel, H. Seltmann and C. E. Orfanos,
Ch.C. Zouboulis. Berlin, Germany. |
P8.110
Estrogen activity on human skin involves interaction
with the insulin-like growth factor-I (IGF-I) signalling
pathway
E. Makrantonaki, M. Oeff, S. Fimmel, C. E. Orfanos
and Ch. C. Zouboulis. Berlin, Germany. |
P8.111
Microarray analysis of IGF-I and IGF- II regulated gene
expression in human dermal papilla fibroblasts
J. J. Bull, Y. Liu, J. Monson, O. Djahanbakhch and
M. P. Philpott. London, UK. |
P8.112
Corticotropin-releasing hormone is involved in androgendependent
skin disorders
Ch. C. Zouboulis, K. Orlowski, A. Schnitger, E. Glass,
S. Fimmel, N. Hiroi, H. Seltmann, W. Chen, S. R. Bornstein.
Berlin, Duesseldorf and Tainan, Germany and Taiwan. |
P8.113
Cultured sebocytes: A model for studies on the regulation
of steroid acute regulatory protein and cutaneous steroidogenesis
W. Chen, C.-C. Yang, H.-M. Sheu and Ch. C. Zouboulis.
Kaohsiung, Tainan and Berlin, Taiwan and Germany. |
P8.114
Control of androgen receptor expression in human skin
cells and in a reconstituted human epidermis model with
antisense ligonucleotides
S. Fimmel, F. Bonté, R. Kurfürst and Ch. C. Zouboulis.
Berlin and St. Jean de Braye, Germany and France. |
P8.148
Cicatricial alopecia / lichen planopilaris- the Cleveland
Clinic Foundation experience on evaluation, diagnosis
and treatment
W. F. Bergfeld, B. K. Remzi and N. C. Cevasco. Cleveland
and Toledo, USA. |
P8.152
Global evaluation of hair loss in male androgenetic alopecia:
European (EU) training and validation versus US experts
E. Sandraps, D. Herbaut, P. Lelubre, T. Leroy, D. Van
Neste. Tournai, Belgium. |
P8.153
The epidemiology of androgenetic alopecia
Rod Sinclair, Desmond Gan, Melbourne, Australia. |
P8.154
Lack of significant decrease in total hair follicle number
with advancing age
Rod Sinclair, Adam Chapman, Jill Magee, Melbourne,
Australia. |
| |
| Hair Diagnostics,
Therapy |
| |
P9.115
Importance of serum ferritin levels in the diagnosis
of chronic telogen effluvium
M. I. Rendon, G. R. Ciocca and J. I. Gaviria. Miami,
USA. |
P9.116
Optical coherent tomography (OCT): a new method for onlinemeasurement
of hair shaft thickness
U. Blume-Peytavi. Berlin, Germany. |
P9.117
Effectiveness of the association cetirizine – topical
steroids in some cases of lichen planus-pilaris and pseudoarea
of brocq - pilot study
R. d’Ovidio, J. Claudatus and T. Di Prima. Catania,
Italy. |
P9.118
Does aminexil prevent hair loss in patients with androgenetic
alopecia who stop finasteride treatment?
C. Vincenzi, A. Rossi, C. Cantisani, M. Pazzaglia and
A. Tosti. Bologna and Rome, Italy. |
P9.119
Topical diphenylcypropenone (DPCP) for the treatment
of extensive alopecia areata
G.-S. Choi, S.-K. Lee and J.-H. Shin. Incheon, Korea. |
P9.120
Minoxidil 5% topical solution is effective in patients
with previous treatment failure of finasteride or 17-alpha
estradiol
K. Mulzer and J. Rundegren. Karlsruhe and Helsingborg,
Germany and Sweden. |
P9.121
Efficacy of minoxidil 5% topical solution in the treatment
of androgenetic alopecia is not influenced by hair colour
K. Mulzer and J. Rundegren. Karlsruhe and Helsingborg,
Germany and Sweden. |
P9.122
Is it ethical to use placebo controls in male pattern hair
loss studies when we have effective active controls?
D. H. Rushton and I. D. Ramsay. London, UK. |
P9.123
A randomized trial of adenosine in androgenetic alopecia
Y. Watanabe, K. Nagashima, N. Hanzawa, M. Ogo, A. Ishino,
Y. Nakazawa, M. Uemura, and M. Tajima. Yokohama and
Tokyo, Japan. |
P9.124
Bilateral double-lined scleroderma en coup de sabre treated
with an oral vitamin D analogue
V. Verlinden, V. Meuleman, S. Segaert and H. Degreef.
Leuven, Belgium. |
P9.125
The effect of 1mg finasteride daily in treatment of androgenic
alopecia in women
A. Tarajkowska-Olejnik and L. Rudnicka. Warsaw, Poland. |
P9.126
Effects of the mixture of herbal medicine extracts on
hair growth in C3H mice and patients with androgenetic
alopecia
M. Tanaka, T. Yamaguchi, D. Matsuura, Z. Kawakami,
S. Takeda, M. Aburada,S. Watanabe and S. Arase. Ibaraki,
Tokyo and Tokushima, Japan. |
P9.127
The herbal mixture xiantene had significant effects on
hair growth in a preliminary double-blind, vehicle-controlled
study in men with androgenic alopecia
P. G. Davies and V. A. Randall. Bradford, UK. |
P9.128
Atrophic telogen effluvium’ from cytotoxic drugs and
an investigation into a protective effect of pretreatment
with a topical vitamin D3 analogue in man
T. O. Blieker, N. Nicolaou, J. Traulsen and P. E. Hutchinson.
Leicester, UK. |
P9.129
Novel and established potassium channel openers stimulate
hair follicle growth in vitro and their effects are opposed
by inhibitors: implications for their modes of action
in hair follicles
G. C. Davies, M. Julie Thornton, T. J. Jenner, Y. C.
Chen, J. B. Hansen, R. D. Carr and V. A. Randall. Bradford
and Bagsvaerd, UK and Denmark. |
P9.130
Effectiveness of finasteride on patients with male pattern
baldness who have different androgen receptor gene polymorphism
K. Kobayashi, N. Wakisaka, Y.-I Taira, M. Ishikawa,
Y. Nakamizo, M. Uwabu, Y. Fukuda, Y. Taguchi, T. Hama
and M. Kawakami. Tokyo, Japan. |
P9.149
Authenticity of long curated historical hair samples
- the case of Newton’s Hair
A. S. Wilson, M. P. Richards, M. Thomas and P. Gilbert.
Bradford and Tucson, UK and USA. |
| |
| Hair Care, Hair Surgery,
Epilation |
| |
P10.131
In vitro fungicidal efficiency of ciclopiroxolamine alone
and associated to pyrithione zinc against malassezia
species
C. Roques, M. Jeanjean, V. Ermosilla, V. Sibaud and
C. Panizzutti. Toulouse and Castanet Tolosan, France. |
P10.132
Three etiologic facets of dandruff and seborrheic dermatitis:
Malassezia fungi, seba- ceous lipids, and individual
sensitivity
Y. M. DeAngelis, M. O. Leland, T. Boekhout, J. R. Kaczvinsky,
S. Whitaker, D. Keanneally, J. R. Schwartz and T. L.
Dawson Jr.. Cincinnati and Utrecht, USA and The Netherlands. |
P10.133
A retrospective assessment of response to treatment with
1% pyrithione zinc shampoo in african americans with
moderate to severe dandruff/seborrheic dermatitis
W. L. Billhimer and M. A. Copas. Cincinnati, USA. |
P10.134
GP4G stimulates human hair follicle cells metabolism
and growth in organ culture
S. Lachgar, L. Fort-Lacoste, V. Ermosilla and M. Charvéron.
Toulouse, France. |
P10.135
An investigation of the impact of ZPT containing anti-dandruff
shampoos on scalp irritation and itch associated with
dandruff
K. M. Kerr, J. R. Schwartz, D. C. Kenneally and C.
H. Margraf. Cincinnati, USA. |
P10.136
The damage and restoration of integral hair lipid following
treatment with hair dye
S. H. Chun, E. Lee , M. S. Song, T. H. Oh and W.-S.
Lee. Wonju, Korea. |
P10.137
The damage and restoration of hair lipid barrier following
treatment with permanent hair waving
S. H. Chun, E. Lee , M. S. Song, and W.-S. Lee. Wonju,
Korea. |
P10.138
Amino acids - improving hair fibre properties in cosmetic
hair problems
C. Gummer and S. Shiel. Egham, UK. |
P10.139
Interest in gamma-cyclodextrin in the formula of a hair-loss
lotion : evaluation by sensory metrology
I. Bacle, S. Meges, P. Lefrançois, J. J. Voisard, M.
Luspot, S. Chesnoy, M. Delaunois and P. Morinet. Vigoulet,
France. |
P10.140
Exogenous hair damage: light microscopy of human hair
shafts after in-vitro damage and application of hair
care products
A. M. Finner, J. Welzel. Berlin and Luebeck, Germany. |
P10.141
Effectiveness of serenoa repens on androgenetic alopecia
C. Fasulo, A. Linguiti, L. Bosco, P. Morranti and R.
A. Satriano. Battipaglia and Naples, Italy. |
P10.142
Molecular mechanism of the hair growth promoting effect
by the combination of 6-benzylaminopurine and pentadecanoic
acid
T. Midorikawa, T. Chikazawa, N. Sato, T. Yoshino and
K. Takada. Odawawara, Japan. |
P10.143
Follicular unit transplantation: the option of beard
construction in eunuchoid man
K. Sahinoglu and S. Sonmez Ergün. Istanbul, Turkey. |
P10.144
Combined treatment with laser and topical eflornithine
is more effective than laser treatment alone for removing
unwanted facial hair – a placebo-controlled trial
E.Tan, I. Hamzavi, J. Shapiro and H. Lui. Vancouver,
Canada. |
P10.145
Evaluations of photo-epilation effect by gross observations
are reliable?
C. Huh, J. Oh and K. Park. Kyounggi and Seoul, Korea. |
